CDSCO UID IMP/MD/2018/000214_32b1f06d1df8d5163d1dc0da97a3cd89_e7048edc8ed2077e68ed95e4d24762e3

qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 in cervical secretions during pregnancy.

Bharat Serums And Vaccines Limited·Device Class Class B·India CDSCO·Brand: insulin-like growth factor binding protein-1
Registration details
UID
IMP/MD/2018/000214_32b1f06d1df8d5163d1dc0da97a3cd89_e7048edc8ed2077e68ed95e4d24762e3
Device class
Class B
Brand name
insulin-like growth factor binding protein-1
Approving authority
CDSCO
Product information
Actim® Partus test is a visually interpreted, qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 (insulin-like growth factor binding protein-1) in cervical secretions during pregnancy. The test is intended for professional use to help predict the risk of preterm or imminent delivery when fetal membranes are intact.
Other products from Bharat Serums And Vaccines Limited
Products from the same license holder (3 products)
Prefillable Glass barrel with Needle
Brand: BD Hypak SCF™
Class B
Qualitative test for detection of Amniotic fluid in vaginal secretion
Brand: Actim Prom Kit
Class B
Actim Pancreatitis
Brand: Actim Pancreatitis
Class B
About this record

qualitative immunochromatographic dipstick test for detecting the presence of phosphorylated IGFBP-1 in cervical secretions during pregnancy. is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000214_32b1f06d1df8d5163d1dc0da97a3cd89_e7048edc8ed2077e68ed95e4d24762e3. This device is marketed under the brand name insulin-like growth factor binding protein-1. The license holder is Bharat Serums And Vaccines Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.